According to Future Market Insights research, during the projected period, the global IV disposables market is expected to grow at a CAGR of 11.8%. The market value is projected to increase from US$ 17.0 Billion in 2023 to US$ 51.6 Billion by 2033. The IV disposables market was valued at US$ 15.5 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 9.6% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 15.5 Billion |
| Market Value 2023 | US$ 17.0 Billion |
| Market Value 2033 | US$ 51.6 Billion |
| CAGR 2023 to 2033 | 11.8% |
| Share of Top 5 Countries | 60.4% |
| Key Players | The key players in the IV disposables market are B. Braun Melsungen AG; Baxter; 3M; Terumo Corporation; Nipro Corporation; Teleflex Incorporated; Becton; Dickinson and Company; Smiths Medical/ICU Medical; Moog Inc; AngioDynamics.; Fresenius SE & Co. KgaA; arcomed ag |
IV disposables, also known as intravenous disposables, are medical devices and accessories used in intravenous therapy to administer fluids, medications, and other substances directly into a patient's bloodstream. These disposable products are designed for single use and are discarded after each patient to minimize the risk of contamination and infection.
An increasing number of chronic diseases demanding disposable IV therapy products is expected to be a major factor driving the growth of the global disposable IV therapy products market over the forecast period.
Overall, the increasing number of chronic diseases due to several factors is likely to boost the market in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the IV disposables market grew at a CAGR of 8.6% between 2018 to 2022. IV disposables market contributes 11.5% revenue share to the global medical supplies market which is valued around US$ 134.2 Billion 2022.
The demand for IV disposables has been steadily increasing due to factors such as the rising prevalence of chronic diseases, an aging population, and the expansion of healthcare infrastructure.
Diabetes is one of the leading cause of kidney failure, lower-limb amputations, and new cases of impaired vision among adults. Moreover, health risks by the dearth of exercise, high alcohol and tobacco consumption, and poor nutrition cause much illness and early death due to chronic diseases.
The market is expected to continue growing during the forecast period. Factors such as the increasing prevalence of chronic diseases, ongoing advancements in medical technology, and the expansion of healthcare services in developing regions are likely to drive the market's growth.
The COVID-19 pandemic has highlighted the importance of IV therapy in critical care settings, further emphasizing the need for IV disposables. The market is also expected to benefit from the continued focus on infection control and the adoption of advanced healthcare technologies.
Considering this, FMI expects the global market to grow at a CAGR of 11.8% through the forecasted years.
The demand for IV therapy has increased as the prevalence of chronic diseases like diabetes, cancer, and coronary artery disease has increased. IV disposables are essential for giving patients their fluids, drugs, and nutrition, which opens up new business prospects for providers and manufacturers.
Technological advancements in the intravenous equipment market include smart pumps, wireless and remote monitoring, needle-free ports, closed system transfer devices, portable intravenous devices, and nanotechnology. These advances have the potential to improve the safety, effectiveness, and efficiency of intravenous therapy and create new opportunities for manufacturers in this market.
There is a growing demand for smart pumps, a type of infusion pumps, that use advanced software algorithms to improve the accuracy and safety of intravenous drug administration. They can detect potential errors, such as incorrect dosages or administration rates, and alert healthcare professionals. These factors can open up several opportunities in the intravenous equipment market.
Principal Consultant
The high cost of intravenous equipment can limit their acceptability in some healthcare settings, especially those with limited budgets. Healthcare providers may opt for lower-cost alternatives, such as oral medications or subcutaneous injections, which may limit the growth of the intravenous equipment market. Healthcare providers may face lower profit margins due to the high cost of intravenous equipment, which may limit their willingness to invest in new equipment or expand their services.
Product recalls can affect the intravenous equipment market in the United States by damaging brand reputation, reducing revenue, increasing regulatory scrutiny, raising patient safety concerns, and increasing litigation costs. Product recalls can raise patient safety concerns and limit the adoption of intravenous equipment by healthcare providers. This may impact the overall growth of the intravenous equipment market.
Some of the factors that can increase demand for alternative therapies include reducing demand, limiting cost-effectiveness, patient preference, limiting investment in innovation and research, and regulatory challenges. Alternative therapies may be more cost-effective for healthcare providers and insurance companies because they require less equipment and human resources. This may limit the adoption of intravenous equipment and affect the overall growth of the market.
These factors are expected to hamper the revenue growth of the market over the forecast period.
The USA market is expected to register a CAGR of 10.3% during the forecast period.
The demand for IV disposables in the USA is driven by factors such as the aging population, the need for improved patient care and safety, the expansion of healthcare infrastructure, and the growing focus on infection control.
The USA market is highly competitive, with several prominent companies operating in the industry. These companies compete based on factors such as product innovation, pricing strategies, distribution networks, and relationships with healthcare providers, which will drive the expansion of the market.
Germany dominated the European market for IV disposables and accounted for around 29.8% of the market share in 2022.
Germany has a robust healthcare infrastructure with a well-established network of hospitals, clinics, and healthcare facilities. The country is known for its high-quality healthcare services and advanced medical technology. This infrastructure creates a favorable environment for the adoption and utilization of IV disposables, driving market growth.
Germany is a lucrative segment of the market in Europe. The strong healthcare infrastructure, technological advancements, aging population, stringent regulations, reimbursement system, medical tourism, and emphasis on research and development create a favorable market landscape for IV disposable manufacturers and suppliers.
China is projected to be the most attractive market in IV disposables and is expected to grow over a significant CAGR of 11.8%.
The market in China is expected to grow significantly in the coming years due to several factors. China has been increasing its healthcare expenditure in recent years, with a focus on improving healthcare infrastructure and services. This increased investment in the healthcare sector is expected to drive the demand for IV disposables as the country seeks to enhance patient care and treatment outcomes.
Another factor contributing to the growth of the market in China is the prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer is on the rise in China, primarily due to factors like an ageing population, sedentary lifestyles, and changing dietary patterns. IV therapy is often necessary for the management and treatment of these chronic conditions, leading to an increased demand for IV disposables.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The infusion pumps segment held the major chunk of about 48.1% of the global market by the end of 2022.
Infusion pumps offer precise and controlled administration of fluids, medications, and nutrition to patients. They are designed to deliver these substances at specific rates and volumes, ensuring accuracy and consistency in dosage. This level of precision is critical in many medical scenarios, such as critical care, chemotherapy, and pain management.
IV disposables, such as specialized connectors and pressure sensors, are designed to work in conjunction with infusion pumps to ensure the safe and accurate delivery of fluids and medications.
Overall, infusion pumps are a widely adopted treatment option for IV Disposables due to their precise and controlled administration of fluids and medications, enhanced safety features, and compatibility with various IV disposables.
The hospitals accounted for a revenue share of 54.6% in the global market at the end of 2022.
Hospitals typically have a significantly higher volume of patients compared to other healthcare settings such as clinics or ambulatory surgical centers. This higher patient load translates into greater demand for IV therapy, which drives the need for IV disposables. Hospitals often have multiple departments and units that administer IV treatments, including emergency departments, intensive care units, operating rooms, and general wards, further contributing to the demand for IV disposables.
Hospitals primarily provide inpatient services, where patients stay for an extended period during treatment or recovery. In such cases, patients often require continuous or intermittent IV therapy throughout their hospital stay. This continuous demand for IV disposables further solidifies the dominance of hospitals in the IV disposable market.
Key players in the market are focused on increasing their product portfolio for strengthening their position in the market and to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain a competitive edge in the market is pricing strategies, market strategies, technological advancements, and acquisition with other companies to expand their business.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the IV disposables market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, Nordics, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Product, End User, and Region |
| Key Companies Profiled | B. Braun Melsungen AG; Baxter; 3M; Terumo Corporation; Nipro Corporation; Teleflex Incorporated; Becton, Dickinson and Company; Smiths Medical/ICU Medical; Moog Inc; AngioDynamics.; Fresenius SE & Co. KgaA; arcomed ag |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 17.0 billion in 2023.
B. Braun Melsungen AG, Baxter International Inc., and 3M are key market players.
The healthcare industry is the key consumer of the IV disposables market.
The market is estimated to reach US$ 51.6 billion by 2033.
The IV Disposables Market CAGR for 2033 is 11.8%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Value-Added Insights
4.1. Disease Epidemiology
4.2. Regulatory Scenario
4.3. Value Chain Analysis
4.4. Technological Advancements
4.5. Cost per Infusion Pump
4.6. PESTLE Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Spending Outlook
5.1.3. Global Medical Supplies Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increase in Medical Procedures
5.2.2. Recent Key Player Activities
5.2.3. Rise in Life Expectancy
5.2.4. Increasing use of Infusion Pumps in Healthcare Settings and Home use
5.2.5. Global Vaccination Programs
5.2.6. Rising Acute and Chronic Cases
5.2.7. Increased Training Programs
5.2.8. GDP Growth
5.2.9. Increase in Number of Companies with Sole Focus on Providing High-Quality IV Tubing
5.2.10. Impact of Covid-19 on Sales
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By End User
6.1.3. By Country
6.2. 2022 Market Scenario
7. Global Market Demand Volume (Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2018 to 2022
7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market Demand Pricing Analysis 2018 to 2022 and Forecast, 2023 to 2033
8.1. Regional Pricing Analysis
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis 2018 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
9.3. Revenue Opportunity Scenario
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
10.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Product, 2023 to 2033
10.3.1. Intravenous Administration Set
10.3.2. IV Fluid Solution Bags
10.3.3. IV Cannula
10.3.4. Infusion Sets
10.3.5. Infusion Pumps
10.3.6. Catheter Needles
10.3.7. Securement Devices
10.3.8. Others (Stopcocks, connectors, Extention Tubes)
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By End User, 2018 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Specialty Clinics
11.3.4. Home Care Settings
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
12.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
13.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. USA
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country-Level Analysis & Forecast
13.8.1. USA Market
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By End User
13.8.2. Canada Market
13.8.3. Introduction
13.8.4. Market Analysis and Forecast by Market Taxonomy
13.8.4.1.1. By Product
13.8.4.1.2. By End User
14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
14.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country-Level Analysis & Forecast
14.8.1. Brazil Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By End User
14.8.2. Mexico Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By End User
14.8.3. Argentina Market
14.8.4. Introduction
14.8.5. Market Analysis and Forecast by Market Taxonomy
14.8.5.1.1. By Product
14.8.5.1.2. By End User
15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
15.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. UK
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Nordic Countries
15.3.1.9. Rest of Europe
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. Germany Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By End User
15.8.2. Italy Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By End User
15.8.3. France Market
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By End User
15.8.4. UK Market
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By End User
15.8.5. Spain Market
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By End User
15.8.6. BENELUX Market
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By End User
15.8.7. Russia Market
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By End User
15.8.8. Nordic Countries Market
15.8.8.1. Introduction
15.8.8.2. Market Analysis and Forecast by Market Taxonomy
15.8.8.2.1. By Product
15.8.8.2.2. By End User
16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
16.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. China Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By End User
16.8.2. Japan Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By End User
16.8.3. South Korea Market
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By End User
17. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
17.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Malaysia
17.3.1.3. Thailand
17.3.1.4. Indonesia
17.3.1.5. Philippines
17.3.1.6. Vietnam
17.3.1.7. Rest of South Africa
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. India Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By End User
17.8.2. Indonesia Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By End User
17.8.3. Malaysia Treatment Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By End User
17.8.4. Thailand Market
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By End User
17.8.5. Philippines Market
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast by Market Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By End User
17.8.6. Vietnam Market
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast by Market Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By End User
18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
18.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. Australia Treatment Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By End User
18.8.2. New Zealand Treatment Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By End User
19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) & Volume (Units) Analysis, By Market Taxonomy 2018 to 2022
19.3. Current and Future Market Size (US$ Million) & Volume (Units) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. South Africa
19.3.1.4. North Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country-Level Analysis & Forecast
19.8.1. GCC Countries Market
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By End User
19.8.2. Türkiye Market
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By End User
19.8.3. Israel Market
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By End User
19.8.4. South Africa Market
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By End User
19.8.5. North Africa Market
19.8.5.1. Introduction
19.8.5.2. Market Analysis and Forecast by Market Taxonomy
19.8.5.2.1. By Product
19.8.5.2.2. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis (%) of Top Players
20.3. Market Presence Analysis
20.3.1. Regional Footprint of Players
20.3.2. Channel Foot Print by Players
20.3.3. Product Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Key Development Analysis
21.3. Promotional and Branding Strategies by Manufacturers
21.4. Competition Deep Dive
21.4.1. B. Braun Melsungen AG
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Sales Footprint
21.4.1.4. Key Financials
21.4.1.5. SWOT Analysis
21.4.1.6. Strategy Overview
21.4.1.6.1. Product Strategy
21.4.1.6.2. Channel Strategy
21.4.1.6.3. Marketing Strategy
21.4.2. Baxter
21.4.2.1. Overview
21.4.2.2. Product Portfolio
21.4.2.3. Sales Footprint
21.4.2.4. Key Financials
21.4.2.5. SWOT Analysis
21.4.2.6. Strategy Overview
21.4.2.6.1. Product Strategy
21.4.2.6.2. Channel Strategy
21.4.2.6.3. Marketing Strategy
21.4.3. 3M
21.4.3.1. Overview
21.4.3.2. Product Portfolio
21.4.3.3. Sales Footprint
21.4.3.4. Key Financials
21.4.3.5. SWOT Analysis
21.4.3.6. Strategy Overview
21.4.3.6.1. Product Strategy
21.4.3.6.2. Channel Strategy
21.4.3.6.3. Marketing Strategy
21.4.4. Terumo Corporation
21.4.4.1. Overview
21.4.4.2. Product Portfolio
21.4.4.3. Sales Footprint
21.4.4.4. Key Financials
21.4.4.5. SWOT Analysis
21.4.4.6. Strategy Overview
21.4.4.6.1. Product Strategy
21.4.4.6.2. Channel Strategy
21.4.4.6.3. Marketing Strategy
21.4.5. Nipro Corporation
21.4.5.1. Overview
21.4.5.2. Product Portfolio
21.4.5.3. Sales Footprint
21.4.5.4. Key Financials
21.4.5.5. SWOT Analysis
21.4.5.6. Strategy Overview
21.4.5.6.1. Product Strategy
21.4.5.6.2. Channel Strategy
21.4.5.6.3. Marketing Strategy
21.4.6. Teleflex Incorporated
21.4.6.1. Overview
21.4.6.2. Product Portfolio
21.4.6.3. Sales Footprint
21.4.6.4. Key Financials
21.4.6.5. SWOT Analysis
21.4.6.6. Strategy Overview
21.4.6.6.1. Product Strategy
21.4.6.6.2. Channel Strategy
21.4.6.6.3. Marketing Strategy
21.4.7. Becton, Dickinson, and Company
21.4.7.1. Overview
21.4.7.2. Product Portfolio
21.4.7.3. Sales Footprint
21.4.7.4. Key Financials
21.4.7.5. SWOT Analysis
21.4.7.6. Strategy Overview
21.4.7.6.1. Product Strategy
21.4.7.6.2. Channel Strategy
21.4.7.6.3. Marketing Strategy
21.4.8. Smiths Medical/ICU Medical
21.4.8.1. Overview
21.4.8.2. Product Portfolio
21.4.8.3. Sales Footprint
21.4.8.4. Key Financials
21.4.8.5. SWOT Analysis
21.4.8.6. Strategy Overview
21.4.8.6.1. Product Strategy
21.4.8.6.2. Channel Strategy
21.4.8.6.3. Marketing Strategy
21.4.9. Moog Inc
21.4.9.1. Overview
21.4.9.2. Product Portfolio
21.4.9.3. Sales Footprint
21.4.9.4. Key Financials
21.4.9.5. SWOT Analysis
21.4.9.6. Strategy Overview
21.4.9.6.1. Product Strategy
21.4.9.6.2. Channel Strategy
21.4.9.6.3. Marketing Strategy
21.4.10. AngioDynamics.
21.4.10.1. Overview
21.4.10.2. Product Portfolio
21.4.10.3. Sales Footprint
21.4.10.4. Key Financials
21.4.10.5. SWOT Analysis
21.4.10.6. Strategy Overview
21.4.10.6.1. Product Strategy
21.4.10.6.2. Channel Strategy
21.4.10.6.3. Marketing Strategy
21.4.11. Fresenius SE & Co. KgaA
21.4.11.1. Overview
21.4.11.2. Product Portfolio
21.4.11.3. Sales Footprint
21.4.11.4. Key Financials
21.4.11.5. SWOT Analysis
21.4.11.6. Strategy Overview
21.4.11.6.1. Product Strategy
21.4.11.6.2. Channel Strategy
21.4.11.6.3. Marketing Strategy
21.4.12. arcomed ag
21.4.12.1. Overview
21.4.12.2. Product Portfolio
21.4.12.3. Sales Footprint
21.4.12.4. Key Financials
21.4.12.5. SWOT Analysis
21.4.12.6. Strategy Overview
21.4.12.6.1. Product Strategy
21.4.12.6.2. Channel Strategy
21.4.12.6.3. Marketing Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
IV Disposables Market
